On ECHEMI
Home > Drugs > Shanghai Kaibao Xinyi(Xinxiang)Pharmaceutical Co., Ltd.
Shanghai Kaibao Xinyi(Xinxiang)Pharmaceutical Co., Ltd.
  • Founded in:

    1998-07-25
  • Country:

    China China
  • Address:

    No. 399, Qinglong Road, Xinxiang Economic Development Zone
  • Tax NO.:

    91410721706782120Y
  • Registered Funds:

    82 million yuan
  • Website:

  • Email:

Related Drugs
Compound Lophatherum gracile tablets
Name Description Content CAS NO. Registered Holders
Compound Lophatherum gracile tablets

It can lower the blood pressure of dogs with experimental renal hypertension; slow down the heart rate of dogs and cats; counteract arrhythmias in rats, which may be related to affecting the influx of calcium ions; reduce the spontaneous activity of mice and have a synergistic effect with sodium pentobarbital.

More

It can lower the blood pressure of dogs with experimental renal hypertension; slow down the heart rate of dogs and cats; counteract arrhythmias in rats, which may be related to affecting the influx of calcium ions; reduce the spontaneous activity of mice and have a synergistic effect with sodium pentobarbital.

0
Sulpiride Tablets
The main ingredient of this product is Sulpiride, and its chemical name is: N-[methyl-(1-ethyl-2-pyrrolidinyl)]-2-methoxy-5-aminosulfonyl)-benzamide.
Name Description Content CAS NO. Registered Holders
Sulpiride

This product belongs to the benzamide antipsychotic drug. Its characteristic action is to selectively block the dopamine (DA2) receptors of the mesolimbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric juice secretion inhibitory effects.

More

This product belongs to the benzamide antipsychotic drug. Its characteristic action is to selectively block the dopamine (DA2) receptors of the mesolimbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric juice secretion inhibitory effects.

15676-16-1 11
Ichthyol ointment
The main ingredient of this product is ichthyol.
Name Description Content CAS NO. Registered Holders
ICHTHOSULFONATE

This product is a disinfectant and antiseptic drug with mild irritation and anti-inflammatory, antiseptic and detumescent effects.

More

This product is a disinfectant and antiseptic drug with mild irritation and anti-inflammatory, antiseptic and detumescent effects.

8029-68-3 6
Racemic Anisodamine Tablets
The main ingredient of this product is racemic anisodamine. Its chemical name is (±)-6β-hydroxy-1aH, 5aH-tropane-3a-ol tropate.
Name Description Content CAS NO. Registered Holders
Anisodamine

Anticholinergic drugs can significantly relieve gastrointestinal smooth muscle spasm

More

Anticholinergic drugs can significantly relieve gastrointestinal smooth muscle spasm

17659-49-3 6
Tolbutamide Tablets
Tolbutamide
Name Description Content CAS NO. Registered Holders
TOLBUTAMIDE

1. Stimulate the pancreatic beta cells to secrete insulin, the prerequisite is that the pancreatic beta cells still have a certain ability to synthesize and secrete insulin; 2. By increasing the level of portal vein insulin or directly acting on the liver, inhibiting liver glycogenolysis and gluconeogenesis, the liver produces and outputs less glucose; 3. It may also increase the sensitivity of extra-pancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to lower fasting blood sugar and postprandial blood sugar.

More

1. Stimulate the pancreatic beta cells to secrete insulin, the prerequisite is that the pancreatic beta cells still have a certain ability to synthesize and secrete insulin; 2. By increasing the level of portal vein insulin or directly acting on the liver, inhibiting liver glycogenolysis and gluconeogenesis, the liver produces and outputs less glucose; 3. It may also increase the sensitivity of extra-pancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to lower fasting blood sugar and postprandial blood sugar.

64-77-7 16
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.